Tomohide Tamura Selected Research

Tomohide Tamura Research Topics

Disease

104	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 02/2002
100	Neoplasms (Cancer) 01/2019 - 02/2002
33	Lung Neoplasms (Lung Cancer) 03/2021 - 07/2002
21	Disease Progression 01/2023 - 02/2002
21	Neutropenia 05/2019 - 02/2005
18	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2019 - 01/2002
12	Thrombocytopenia (Thrombopenia) 01/2017 - 10/2005
11	Diarrhea 05/2019 - 01/2002
10	Nausea 11/2023 - 06/2003
8	Adenocarcinoma of Lung 12/2019 - 08/2002
8	Neoplasm Metastasis (Metastasis) 01/2018 - 05/2007
8	Leukopenia 01/2017 - 10/2005
7	Vomiting 11/2023 - 06/2003
7	Breast Neoplasms (Breast Cancer) 02/2020 - 02/2008
6	Interstitial Lung Diseases (Interstitial Lung Disease) 02/2020 - 07/2004
6	Febrile Neutropenia 05/2019 - 01/2014
6	Hypertension (High Blood Pressure) 04/2017 - 11/2006
6	Carcinoma (Carcinomatosis) 04/2014 - 08/2002
5	Pneumonia (Pneumonitis) 08/2016 - 10/2006
5	Colorectal Neoplasms (Colorectal Cancer) 05/2014 - 02/2002
5	Stomach Neoplasms (Stomach Cancer) 12/2011 - 05/2007
4	Fever (Fevers) 03/2019 - 07/2006
4	Anemia 01/2019 - 08/2006
4	Anorexia 01/2017 - 08/2010
4	Exanthema (Rash) 12/2015 - 01/2010
3	Lung Injury 02/2020 - 07/2006
3	Pleural Effusion (Pleural Effusions) 03/2019 - 07/2006
3	Headache (Headaches) 04/2017 - 11/2006
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2017 - 08/2002
3	Fatigue 02/2016 - 06/2003
3	Proteinuria 12/2015 - 11/2009
3	Stomatitis 03/2014 - 08/2010
3	Radiation Pneumonitis 01/2014 - 07/2006
3	Adenocarcinoma 07/2004 - 08/2002
2	Bronchiectasis 12/2021 - 01/2017
2	Thymoma (Thymic Carcinoma) 03/2020 - 08/2011
2	Melanoma (Melanoma, Malignant) 01/2018 - 10/2017

Drug/Important Bio-Agent (IBA)

39	Cisplatin (Platino)FDA LinkGeneric 11/2023 - 01/2002
32	ErbB Receptors (EGF Receptor)IBA 01/2023 - 02/2002
23	PlatinumIBA 01/2023 - 10/2002
22	Gefitinib (Iressa)FDA Link 01/2023 - 02/2002
20	Paclitaxel (Taxol)FDA LinkGeneric 01/2023 - 12/2003
18	Tyrosine Kinase InhibitorsIBA 01/2023 - 02/2002
17	Carboplatin (JM8)FDA LinkGeneric 01/2023 - 04/2005
16	Irinotecan (Camptosar)FDA LinkGeneric 08/2016 - 01/2002
14	Docetaxel (Taxotere)FDA Link 03/2021 - 10/2003
12	Erlotinib Hydrochloride (CP 358,774)FDA Link 02/2017 - 02/2002
11	Biomarkers (Surrogate Marker)IBA 12/2015 - 11/2005
8	NivolumabIBA 01/2023 - 01/2016
8	Pemetrexed (MTA)FDA Link 01/2019 - 07/2008
8	Phosphotransferases (Kinase)IBA 01/2019 - 05/2011
8	amrubicinIBA 01/2017 - 03/2010
8	Etoposide (VP 16)FDA LinkGeneric 08/2016 - 01/2002
7	alectinibIBA 01/2020 - 06/2013
6	CrizotinibIBA 01/2020 - 06/2013
6	Alanine Transaminase (SGPT)IBA 01/2019 - 12/2003
5	Gemcitabine FDA Link 06/2019 - 02/2002
5	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2019 - 10/2005
5	Monoclonal AntibodiesIBA 01/2016 - 02/2002
5	Vinorelbine (Navelbine)FDA LinkGeneric 08/2013 - 08/2004
5	Proteins (Proteins, Gene)FDA Link 02/2012 - 01/2004
5	Antineoplastic Agents (Antineoplastics)IBA 02/2008 - 02/2002
5	DNA (Deoxyribonucleic Acid)IBA 07/2006 - 08/2002
4	Palonosetron (Aloxi)FDA Link 11/2023 - 02/2019
4	lenvatinibIBA 12/2019 - 04/2011
4	Hemoglobins (Hemoglobin)IBA 08/2015 - 08/2006
3	Dexamethasone (Maxidex)FDA LinkGeneric 11/2023 - 02/2016
3	Neurokinin-1 Receptor AntagonistsIBA 01/2022 - 02/2019
3	necitumumabIBA 06/2019 - 11/2016
3	Anaplastic Lymphoma KinaseIBA 01/2018 - 01/2017
3	Histone Deacetylase InhibitorsIBA 01/2017 - 09/2009
3	SteroidsIBA 01/2017 - 07/2006
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2015 - 05/2011
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2014 - 11/2009
3	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 07/2014 - 10/2010
3	Cetuximab (Erbitux)FDA Link 05/2014 - 02/2002
3	CreatinineIBA 11/2013 - 12/2009
3	Cytochrome P-450 CYP3AIBA 08/2008 - 02/2005
3	vandetanib (ZD6474)IBA 11/2006 - 12/2004
3	Topoisomerase I InhibitorsIBA 08/2006 - 01/2002
2	Bevacizumab (Avastin)FDA Link 01/2023 - 06/2006
2	fosaprepitant FDA Link 10/2022 - 06/2022
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 07/2006
2	B7-H1 AntigenIBA 06/2020 - 09/2015
2	ProdrugsIBA 11/2019 - 06/2013
2	Immune Checkpoint InhibitorsIBA 01/2019 - 01/2016
2	Tyrosine (L-Tyrosine)FDA Link 01/2019 - 05/2011
2	IpilimumabIBA 10/2017 - 08/2015
2	RamucirumabIBA 04/2017 - 01/2016
2	resminostatIBA 01/2017 - 06/2015

Therapy/Procedure

63	Drug Therapy (Chemotherapy) 11/2023 - 02/2002
43	Therapeutics 01/2021 - 02/2002
24	Radiotherapy 03/2020 - 07/2002
17	Chemoradiotherapy 01/2017 - 08/2003
4	Combination Drug Therapy (Combination Chemotherapy) 08/2016 - 08/2011
4	Intravenous Infusions 02/2016 - 04/2008
3	Adjuvant Chemotherapy 09/2014 - 06/2006
2	Aftercare (After-Treatment) 11/2023 - 06/2011
2	Traction 12/2021 - 01/2017
2	Immunotherapy 12/2019 - 01/2017